HBV Vaccines
"Immune Response of Immunocompromised Children with Malignancies to a Recombinant Hepatitis B Vaccine."
Published in Hepatitis Weekly, October 28th, 1996
According to the authors' abstract of an article published in Pediatric Hematology and Oncology, "The aim of this study was to interpret the antibody response to hepatitis B vaccination following an intensified four-dose schedule in 140 cancer patients who presented at our clinic between January 1, 1993 and December 31, 1994. According to therapy status, the patients were divided into two groups: group A consisted of 76 patients undergoing chemotherapy and group B of 64 patients in complete remission and off treatment. The eligibility requirements were negative hepatitis B virus (HBV), HCV and human immunodeficiency virus serologic markers. A total of four doses (20 (mu)g per dose) of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-10-28)
More Articles from Hepatitis Weekly
- Disease Associations (HCV)
Hepatitis C May Be a Cause of Diabetes - Autoimmune Hepatitis
Recognition of Variant Forms Critical in Disease Treatment - Conference Coverage (ICAAC)
Six-Disease Vaccine Hailed as "Wave of Future" - Diagnostics (HCV)
Three Procedures Reliable in Genotyping Hepatitis C - HBV Vaccines
Lowering Dosage May Affect Long-Term Efficacy in Infants - Infection Control
Bacteria and Virus Passage Through Surgical Latex Gloves Confirmed - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
